Tag: Blood Disorders
FDA Warns About ‘Miracle’ Young Blood Infusion Treatments
Expensive 'fountain of youth' therapies are unproven, potentially harmful
Sepsis Common in Terminal Hospitalizations, Discharges
Most common underlying causes of death in sepsis are solid and hematologic cancers, chronic heart disease
Blood Type A2 to B Kidney Transplant Feasible
No difference in patient, graft survival; increased costs seen for A2 to B deceased donor kidney transplant
Blood Conservation Safe, Effective During Heart Surgery
Intraoperative autologous donation strategy leads to improved outcomes
Hemochromatosis Mutation Linked to Other Morbidity
Higher rates of at least one incident-linked condition seen in men, women with HFE p.C282Y homozygosity
Red Cross Issues Emergency Call for Blood Donations
People nationwide, especially those with type O blood, are urged to donate as soon as possible
Screening Donated Blood for Zika Not Cost-Effective
Universal mini-pool nucleic acid testing only during high mosquito activity cost-effective in Puerto Rico
FDA Approves Drugs for Treatment of Two Rare Blood Diseases
Elzonris approved to treat BPDCN; Ultomiris approved for paroxysmal nocturnal hemoglobinuria
Risk for Zoster Up Before Dx, During Tx of Hematologic Cancer
For solid organ cancers, the risk is greater among those receiving chemotherapy
American Society of Hematology, Dec. 1-4
The 60th American Society of Hematology Annual Meeting and Exposition The annual meeting of the American Society of Hematology was held from Dec....
